An accomplished Managed Markets and Reimbursement Executive with 30+ years of experience in the pharmaceutical industry. Recognized expert in multiple specialty and biotech markets, with proven success with high touch/high cost complex therapies that require devices for route of administration. Leadership of Managed Markets team that includes all aspects of government pricing and all Payer activities. This includes CMS, VA, State Medicaid, and GPO’s/PBM’s. Proven ability to consistently lead a team through Policy/Reimbursement, Pricing, Government Pricing, Contract Strategy and execution, Commercial Account management, and Payer Marketing. Proven success adapting to complex payer channels. Specialties: Specialty Markets: Pulmonary Arterial Hypertension, Pulmonary Hypertension-Interstitial Lung Disease, Oncology, Infertility, Hepatitis C, and Implantable Contraceptives. Oral Therapies: Erectile Dysfunction, Hypercholesterolemia, Non-Sedating Antihistamines, Quinolones, Contraceptives, Anti-Psychotics and Anti-Depressants. Inhaled Dose Therapies: Oral Inhaled Steroids, Nasal Inhaled Steroids, Short Acting Beta Agonists, Long Acting Beta Agonists. Hospital Therapies: Neuromuscular Blocking Agents and 340B outpatient services.